TY - CONF A1 - Nordholt, Niclas A1 - Schreiber, Frank A1 - Kanaris, Orestis T1 - Consequences of BAC tolerance for selection and evolution in the presence of antibiotics N2 - The exposure to antimicrobial substances drives the evolution of antimicrobial resistance. Biocides are antimicrobials used as disinfectants, antiseptics and preservatives. They find application on a large scale in the industrial and medical sector, but also in private households. In terms of mass, the worldwide use of biocides exceeds that of antibiotics. Thus, despite their important role in preventing the spread of pathogens, due to their ubiquity, biocides are suspected to be drivers of the antimicrobial resistance crisis. In our work at BAM we try to understand how biocides contribute to the emergence of AMR, what the underlying adaptation principles and mechanisms are and how they compare to those found for antibiotics. Within our group, I mainly focus on the following two questions: How does phenotypic heterogeneity in bacteria affect the ability to survive treatment with biocides? And what are the consequences of phenotypic heterogeneity for the evolution of resistance to biocides and antibiotics? I will share published and unpublished results which demonstrate that phenotypic heterogeneity can enable the survival of biocide treatment and, through this, facilitate the evolution of AMR. On the other hand, we find that adaptation to a biocide can unexpectedly impair the ability to evolve resistance against an antibiotic. T2 - FEMS summer school for postdocs 2022: Microbial Evolvability Mechanisms: Resistance, Biology, and Strategies to Defeat and Detect CY - Split, Croatia DA - 27.04.2022 KW - Disinfection KW - Biocides KW - Evolution KW - Resistance KW - Biocide tolerance PY - 2022 AN - OPUS4-54846 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Nordholt, Niclas A1 - Schreiber, Frank T1 - Phenotypic heterogeneity in disinfection: sources and consequences for antimicrobial resistance N2 - A summary of projects here at BAM which investigate the influence of phenotypic heterogeneity on the outcome of disinfection and the influence on antimicrobial resistance. This presentation was given in the Theory Seminar of the Quantitative and Theoretical Biology group of Prof. Oliver Ebenhöh at HHU Düsseldorf T2 - Theory Seminar in the Quantitative and Theoretical Biology group at HHU Düsseldorf CY - Düsseldorf, Germany DA - 24.02.2022 KW - Disinfection KW - Biocides KW - Heterogeneity KW - Resistance PY - 2022 AN - OPUS4-54442 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Pietsch, Franziska A1 - Schreiber, Frank T1 - Selection of resistance in bacteria grown on antimicrobial surfaces in a multidrug environment N2 - Bacterial biofilms are regarded as the most common cause of chronic infections and are often associated with medical devices, such as implants and catheters. Bacteria growing in biofilms produce a protective, extracellular matrix, which enables them to tolerate much higher antimicrobial concentrations than free-living bacteria and survive long enough to acquire antimicrobial resistance. Preventive and therapeutic strategies against biofilm infections in clinical settings commonly involve the application of multiple antimicrobials: antimicrobial coatings on the biomaterials and systemically administered antibiotics. This frequent practice harbors the risk of the development of cross-resistance via shared resistance mechanisms between antimicrobials used in material coatings and administered antibiotics. Our goal is to determine how population dynamics within biofilms affect the transmission of resistance mutations. Specifically, we want to identify antimicrobial-antibiotic-combinations that select for and against antibiotic resistance in biofilms by following the population dynamics of resistant and susceptible strains in competition assays. Gaining a better understanding about resistance development and spread in persistent biofilm infections will enable us to provide clinical recommendations for improved administration of antibiotics/antimicrobials in combination with medical device materials to mitigate against biofilm associated antimicrobial resistance. Here, we will discuss our first findings on the effects of combinations of the carbapenem drug meropenem and various antimicrobials. T2 - The Antimicrobial Resistance on Biomaterials Workshop CY - St. Gallen, Switzerland DA - 25.10.2018 KW - Resistance KW - Antimicrobials PY - 2018 AN - OPUS4-46526 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -